IPSWICH, Mass., Nov. 6, 2015 /PRNewswire/ -- New England Biolabs (NEB®) today launched the NEBNext Selector, an online, interactive tool that helps researchers easily determine the optimal NEBNext product for every step in their next generation sequencing (NGS) sample preparation workflow.
"The rapid evolution of NGS technologies can make it difficult for users to keep abreast of the latest options for constructing libraries of the highest quality, including developments for limited or difficult sample types," said Fiona Stewart, NEBNext Product Marketing Manager at NEB. "NEBNext Selector considers a variety of experimental parameters to display the options among NEBNext's growing product portfolio that will work best for the experiment at hand."
This free online tool asks a series of targeted questions related to the user's NGS platform, sample type, desired protocol, and other relevant experimental factors. NEBNext products are then evaluated for optimal utility in the experiment, and a list of options are presented, accompanied by technical data and a direct link for convenient ordering.
NEBNext Selector is compatible with the leading NGS platforms, including Illumina®, and includes all applicable sample types; for example, the Selector can recommend sample prep reagents for Illumina sequencing with DNA, ChIP DNA, FFPE DNA, microbiome DNA, bisulfite-treated DNA, total RNA/mRNA, and small RNA.
NEBNext Selector is available online at NEBNextSelector.neb.com
About New England Biolabs:
Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit http://www.neb.com.
NEB®, and NEW ENGLAND BIOLABS® and NEBNext® are registered trademarks of New England Biolabs, Inc.
ILLUMINA® is a registered trademark of Illumina, Inc.
Ion Torrent™ and SOLiD™ are trademarks of Life Technologies, Inc.
454™ is a trademark of Roche
SOURCE New England Biolabs